nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—epilepsy syndrome	0.577	1	CbGaD
Tafluprost—Common cold—Levetiracetam—epilepsy syndrome	0.00889	0.0353	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Propofol—epilepsy syndrome	0.00546	0.0217	CcSEcCtD
Tafluprost—Iloprost—PLAT—epilepsy syndrome	0.00543	1	CrCbGaD
Tafluprost—Iritis—Zonisamide—epilepsy syndrome	0.00536	0.0212	CcSEcCtD
Tafluprost—Uveitis—Lamotrigine—epilepsy syndrome	0.00515	0.0204	CcSEcCtD
Tafluprost—Uveitis—Pregabalin—epilepsy syndrome	0.0037	0.0147	CcSEcCtD
Tafluprost—Photophobia—Trimethadione—epilepsy syndrome	0.00344	0.0136	CcSEcCtD
Tafluprost—Iritis—Pregabalin—epilepsy syndrome	0.0034	0.0135	CcSEcCtD
Tafluprost—Iritis—Gabapentin—epilepsy syndrome	0.00312	0.0124	CcSEcCtD
Tafluprost—Ocular hyperaemia—Pregabalin—epilepsy syndrome	0.00276	0.0109	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Gabapentin—epilepsy syndrome	0.00269	0.0107	CcSEcCtD
Tafluprost—Eye pruritus—Gabapentin—epilepsy syndrome	0.00265	0.0105	CcSEcCtD
Tafluprost—Iritis—Topiramate—epilepsy syndrome	0.00262	0.0104	CcSEcCtD
Tafluprost—Eyelid oedema—Pregabalin—epilepsy syndrome	0.00256	0.0102	CcSEcCtD
Tafluprost—Eye irritation—Clonazepam—epilepsy syndrome	0.0023	0.00911	CcSEcCtD
Tafluprost—Visual acuity reduced—Pregabalin—epilepsy syndrome	0.00217	0.00861	CcSEcCtD
Tafluprost—Ocular hyperaemia—Topiramate—epilepsy syndrome	0.00213	0.00843	CcSEcCtD
Tafluprost—Photophobia—Fosphenytoin—epilepsy syndrome	0.0021	0.00834	CcSEcCtD
Tafluprost—Endophthalmitis—Topiramate—epilepsy syndrome	0.00209	0.0083	CcSEcCtD
Tafluprost—Nasopharyngitis—Rufinamide—epilepsy syndrome	0.00207	0.00819	CcSEcCtD
Tafluprost—Cataract—Oxcarbazepine—epilepsy syndrome	0.00204	0.00808	CcSEcCtD
Tafluprost—Asthma—Phenobarbital—epilepsy syndrome	0.00204	0.00807	CcSEcCtD
Tafluprost—Eyelid oedema—Topiramate—epilepsy syndrome	0.00198	0.00783	CcSEcCtD
Tafluprost—Eye disorder—Primidone—epilepsy syndrome	0.00195	0.00775	CcSEcCtD
Tafluprost—Eye pain—Propofol—epilepsy syndrome	0.00193	0.00766	CcSEcCtD
Tafluprost—Photophobia—Zonisamide—epilepsy syndrome	0.00191	0.00758	CcSEcCtD
Tafluprost—Photophobia—Phenytoin—epilepsy syndrome	0.00183	0.00726	CcSEcCtD
Tafluprost—Photophobia—Oxcarbazepine—epilepsy syndrome	0.00182	0.00722	CcSEcCtD
Tafluprost—Asthma—Clobazam—epilepsy syndrome	0.00182	0.00722	CcSEcCtD
Tafluprost—Eye pain—Fosphenytoin—epilepsy syndrome	0.0018	0.00714	CcSEcCtD
Tafluprost—Eye pain—Vigabatrin—epilepsy syndrome	0.00176	0.00696	CcSEcCtD
Tafluprost—Photophobia—Lamotrigine—epilepsy syndrome	0.00169	0.00669	CcSEcCtD
Tafluprost—Visual acuity reduced—Topiramate—epilepsy syndrome	0.00168	0.00664	CcSEcCtD
Tafluprost—Dry eye—Lamotrigine—epilepsy syndrome	0.00166	0.00659	CcSEcCtD
Tafluprost—Rhinitis—Rufinamide—epilepsy syndrome	0.0016	0.00636	CcSEcCtD
Tafluprost—Urinary tract infection—Clobazam—epilepsy syndrome	0.00158	0.00626	CcSEcCtD
Tafluprost—Eye pain—Phenytoin—epilepsy syndrome	0.00157	0.00621	CcSEcCtD
Tafluprost—Nasopharyngitis—Midazolam—epilepsy syndrome	0.00153	0.00605	CcSEcCtD
Tafluprost—Eye irritation—Pregabalin—epilepsy syndrome	0.00151	0.006	CcSEcCtD
Tafluprost—Nasopharyngitis—Levetiracetam—epilepsy syndrome	0.00151	0.00597	CcSEcCtD
Tafluprost—Eye disorder—Rufinamide—epilepsy syndrome	0.00149	0.00592	CcSEcCtD
Tafluprost—Nervous system disorder—Primidone—epilepsy syndrome	0.00146	0.00578	CcSEcCtD
Tafluprost—Asthma—Levetiracetam—epilepsy syndrome	0.00146	0.00577	CcSEcCtD
Tafluprost—Eye pain—Lamotrigine—epilepsy syndrome	0.00145	0.00573	CcSEcCtD
Tafluprost—Nasopharyngitis—Vigabatrin—epilepsy syndrome	0.00142	0.00562	CcSEcCtD
Tafluprost—Asthma—Fosphenytoin—epilepsy syndrome	0.00141	0.00557	CcSEcCtD
Tafluprost—Eye disorder—Lacosamide—epilepsy syndrome	0.0014	0.00556	CcSEcCtD
Tafluprost—Lacrimation increased—Pregabalin—epilepsy syndrome	0.0014	0.00556	CcSEcCtD
Tafluprost—Eye disorder—Clobazam—epilepsy syndrome	0.00136	0.0054	CcSEcCtD
Tafluprost—Cataract—Pregabalin—epilepsy syndrome	0.00136	0.00538	CcSEcCtD
Tafluprost—Asthma—Diazepam—epilepsy syndrome	0.00135	0.00535	CcSEcCtD
Tafluprost—Photophobia—Valproic Acid—epilepsy syndrome	0.00134	0.00532	CcSEcCtD
Tafluprost—Dry eye—Valproic Acid—epilepsy syndrome	0.00132	0.00523	CcSEcCtD
Tafluprost—Vision blurred—Rufinamide—epilepsy syndrome	0.00131	0.0052	CcSEcCtD
Tafluprost—Asthma—Felbamate—epilepsy syndrome	0.00131	0.00517	CcSEcCtD
Tafluprost—Lacrimation increased—Gabapentin—epilepsy syndrome	0.00129	0.0051	CcSEcCtD
Tafluprost—Nasopharyngitis—Clonazepam—epilepsy syndrome	0.00127	0.00505	CcSEcCtD
Tafluprost—Urinary tract infection—Levetiracetam—epilepsy syndrome	0.00126	0.005	CcSEcCtD
Tafluprost—Nasopharyngitis—Oxcarbazepine—epilepsy syndrome	0.00126	0.00499	CcSEcCtD
Tafluprost—Cataract—Gabapentin—epilepsy syndrome	0.00124	0.00493	CcSEcCtD
Tafluprost—Vision blurred—Lacosamide—epilepsy syndrome	0.00123	0.00488	CcSEcCtD
Tafluprost—Asthma—Clonazepam—epilepsy syndrome	0.00123	0.00488	CcSEcCtD
Tafluprost—Asthma—Phenytoin—epilepsy syndrome	0.00122	0.00485	CcSEcCtD
Tafluprost—Asthma—Oxcarbazepine—epilepsy syndrome	0.00122	0.00482	CcSEcCtD
Tafluprost—Photophobia—Pregabalin—epilepsy syndrome	0.00121	0.00481	CcSEcCtD
Tafluprost—Vision blurred—Clobazam—epilepsy syndrome	0.0012	0.00474	CcSEcCtD
Tafluprost—Dry eye—Pregabalin—epilepsy syndrome	0.00119	0.00473	CcSEcCtD
Tafluprost—Urinary tract infection—Vigabatrin—epilepsy syndrome	0.00119	0.00471	CcSEcCtD
Tafluprost—Urinary tract infection—Diazepam—epilepsy syndrome	0.00117	0.00463	CcSEcCtD
Tafluprost—Rhinitis—Levetiracetam—epilepsy syndrome	0.00117	0.00463	CcSEcCtD
Tafluprost—Eye pain—Valproic Acid—epilepsy syndrome	0.00115	0.00456	CcSEcCtD
Tafluprost—Urinary tract infection—Felbamate—epilepsy syndrome	0.00113	0.00448	CcSEcCtD
Tafluprost—Asthma—Lamotrigine—epilepsy syndrome	0.00113	0.00447	CcSEcCtD
Tafluprost—Rhinitis—Fosphenytoin—epilepsy syndrome	0.00113	0.00447	CcSEcCtD
Tafluprost—Nervous system disorder—Rufinamide—epilepsy syndrome	0.00111	0.00442	CcSEcCtD
Tafluprost—Photophobia—Gabapentin—epilepsy syndrome	0.00111	0.00441	CcSEcCtD
Tafluprost—Urinary tract infection—Zonisamide—epilepsy syndrome	0.00111	0.00439	CcSEcCtD
Tafluprost—Cough—Clobazam—epilepsy syndrome	0.00111	0.00439	CcSEcCtD
Tafluprost—Eye disorder—Midazolam—epilepsy syndrome	0.0011	0.00437	CcSEcCtD
Tafluprost—Dry eye—Gabapentin—epilepsy syndrome	0.00109	0.00434	CcSEcCtD
Tafluprost—Eye disorder—Levetiracetam—epilepsy syndrome	0.00109	0.00432	CcSEcCtD
Tafluprost—Rhinitis—Diazepam—epilepsy syndrome	0.00108	0.00429	CcSEcCtD
Tafluprost—Lacrimation increased—Topiramate—epilepsy syndrome	0.00108	0.00429	CcSEcCtD
Tafluprost—Urinary tract infection—Clonazepam—epilepsy syndrome	0.00107	0.00423	CcSEcCtD
Tafluprost—Urinary tract infection—Oxcarbazepine—epilepsy syndrome	0.00105	0.00418	CcSEcCtD
Tafluprost—Rhinitis—Felbamate—epilepsy syndrome	0.00105	0.00415	CcSEcCtD
Tafluprost—Nervous system disorder—Lacosamide—epilepsy syndrome	0.00105	0.00415	CcSEcCtD
Tafluprost—Eye pain—Pregabalin—epilepsy syndrome	0.00104	0.00412	CcSEcCtD
Tafluprost—Rhinitis—Zonisamide—epilepsy syndrome	0.00103	0.00406	CcSEcCtD
Tafluprost—Eye disorder—Vigabatrin—epilepsy syndrome	0.00102	0.00406	CcSEcCtD
Tafluprost—Nervous system disorder—Clobazam—epilepsy syndrome	0.00102	0.00402	CcSEcCtD
Tafluprost—Urinary tract infection—Carbamazepine—epilepsy syndrome	0.00101	0.00401	CcSEcCtD
Tafluprost—Eye disorder—Diazepam—epilepsy syndrome	0.00101	0.004	CcSEcCtD
Tafluprost—Rhinitis—Clonazepam—epilepsy syndrome	0.000988	0.00392	CcSEcCtD
Tafluprost—Rhinitis—Phenytoin—epilepsy syndrome	0.000982	0.00389	CcSEcCtD
Tafluprost—Urinary tract infection—Lamotrigine—epilepsy syndrome	0.000978	0.00388	CcSEcCtD
Tafluprost—Rhinitis—Oxcarbazepine—epilepsy syndrome	0.000977	0.00387	CcSEcCtD
Tafluprost—Vision blurred—Midazolam—epilepsy syndrome	0.000969	0.00384	CcSEcCtD
Tafluprost—Headache—Amobarbital—epilepsy syndrome	0.000966	0.00383	CcSEcCtD
Tafluprost—Vision blurred—Levetiracetam—epilepsy syndrome	0.000956	0.00379	CcSEcCtD
Tafluprost—Eye disorder—Zonisamide—epilepsy syndrome	0.000956	0.00379	CcSEcCtD
Tafluprost—Eye pain—Gabapentin—epilepsy syndrome	0.000953	0.00378	CcSEcCtD
Tafluprost—Rhinitis—Carbamazepine—epilepsy syndrome	0.000937	0.00371	CcSEcCtD
Tafluprost—Photophobia—Topiramate—epilepsy syndrome	0.000936	0.00371	CcSEcCtD
Tafluprost—Headache—Primidone—epilepsy syndrome	0.000931	0.00369	CcSEcCtD
Tafluprost—Pruritus—Trimethadione—epilepsy syndrome	0.000925	0.00367	CcSEcCtD
Tafluprost—Eye disorder—Clonazepam—epilepsy syndrome	0.000921	0.00365	CcSEcCtD
Tafluprost—Dry eye—Topiramate—epilepsy syndrome	0.000921	0.00365	CcSEcCtD
Tafluprost—Cough—Propofol—epilepsy syndrome	0.000917	0.00363	CcSEcCtD
Tafluprost—Eye disorder—Oxcarbazepine—epilepsy syndrome	0.00091	0.00361	CcSEcCtD
Tafluprost—Rhinitis—Lamotrigine—epilepsy syndrome	0.000906	0.00359	CcSEcCtD
Tafluprost—Vision blurred—Vigabatrin—epilepsy syndrome	0.0009	0.00357	CcSEcCtD
Tafluprost—Cough—Midazolam—epilepsy syndrome	0.000897	0.00355	CcSEcCtD
Tafluprost—Vision blurred—Diazepam—epilepsy syndrome	0.000886	0.00351	CcSEcCtD
Tafluprost—Cough—Levetiracetam—epilepsy syndrome	0.000886	0.00351	CcSEcCtD
Tafluprost—Eye disorder—Carbamazepine—epilepsy syndrome	0.000874	0.00346	CcSEcCtD
Tafluprost—Cough—Fosphenytoin—epilepsy syndrome	0.000855	0.00339	CcSEcCtD
Tafluprost—Eye disorder—Lamotrigine—epilepsy syndrome	0.000844	0.00335	CcSEcCtD
Tafluprost—Nasopharyngitis—Pregabalin—epilepsy syndrome	0.000839	0.00332	CcSEcCtD
Tafluprost—Cough—Vigabatrin—epilepsy syndrome	0.000833	0.0033	CcSEcCtD
Tafluprost—Nervous system disorder—Midazolam—epilepsy syndrome	0.000823	0.00326	CcSEcCtD
Tafluprost—Cough—Diazepam—epilepsy syndrome	0.00082	0.00325	CcSEcCtD
Tafluprost—Headache—Trimethadione—epilepsy syndrome	0.000819	0.00325	CcSEcCtD
Tafluprost—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000812	0.00322	CcSEcCtD
Tafluprost—Asthma—Pregabalin—epilepsy syndrome	0.000811	0.00321	CcSEcCtD
Tafluprost—Vision blurred—Clonazepam—epilepsy syndrome	0.000809	0.00321	CcSEcCtD
Tafluprost—Pruritus—Rufinamide—epilepsy syndrome	0.000804	0.00319	CcSEcCtD
Tafluprost—Eye pain—Topiramate—epilepsy syndrome	0.000802	0.00318	CcSEcCtD
Tafluprost—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000799	0.00317	CcSEcCtD
Tafluprost—Cough—Felbamate—epilepsy syndrome	0.000794	0.00315	CcSEcCtD
Tafluprost—Urinary tract infection—Valproic Acid—epilepsy syndrome	0.000777	0.00308	CcSEcCtD
Tafluprost—Cough—Zonisamide—epilepsy syndrome	0.000777	0.00308	CcSEcCtD
Tafluprost—Nasopharyngitis—Gabapentin—epilepsy syndrome	0.000769	0.00305	CcSEcCtD
Tafluprost—Vision blurred—Carbamazepine—epilepsy syndrome	0.000767	0.00304	CcSEcCtD
Tafluprost—Dyspnoea—Propofol—epilepsy syndrome	0.000764	0.00303	CcSEcCtD
Tafluprost—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000764	0.00303	CcSEcCtD
Tafluprost—Pruritus—Lacosamide—epilepsy syndrome	0.000755	0.00299	CcSEcCtD
Tafluprost—Nervous system disorder—Diazepam—epilepsy syndrome	0.000752	0.00298	CcSEcCtD
Tafluprost—Cough—Clonazepam—epilepsy syndrome	0.000749	0.00297	CcSEcCtD
Tafluprost—Dyspnoea—Midazolam—epilepsy syndrome	0.000748	0.00296	CcSEcCtD
Tafluprost—Cough—Phenytoin—epilepsy syndrome	0.000744	0.00295	CcSEcCtD
Tafluprost—Asthma—Gabapentin—epilepsy syndrome	0.000744	0.00295	CcSEcCtD
Tafluprost—Vision blurred—Lamotrigine—epilepsy syndrome	0.000741	0.00294	CcSEcCtD
Tafluprost—Cough—Oxcarbazepine—epilepsy syndrome	0.00074	0.00293	CcSEcCtD
Tafluprost—Pruritus—Clobazam—epilepsy syndrome	0.000733	0.0029	CcSEcCtD
Tafluprost—Headache—Phenobarbital—epilepsy syndrome	0.000725	0.00287	CcSEcCtD
Tafluprost—Rhinitis—Valproic Acid—epilepsy syndrome	0.00072	0.00285	CcSEcCtD
Tafluprost—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000713	0.00282	CcSEcCtD
Tafluprost—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.000713	0.00282	CcSEcCtD
Tafluprost—Headache—Rufinamide—epilepsy syndrome	0.000712	0.00282	CcSEcCtD
Tafluprost—Urinary tract infection—Pregabalin—epilepsy syndrome	0.000703	0.00279	CcSEcCtD
Tafluprost—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000687	0.00272	CcSEcCtD
Tafluprost—Cough—Lamotrigine—epilepsy syndrome	0.000686	0.00272	CcSEcCtD
Tafluprost—Dyspnoea—Diazepam—epilepsy syndrome	0.000684	0.00271	CcSEcCtD
Tafluprost—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000682	0.0027	CcSEcCtD
Tafluprost—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000679	0.00269	CcSEcCtD
Tafluprost—Eye disorder—Valproic Acid—epilepsy syndrome	0.000671	0.00266	CcSEcCtD
Tafluprost—Headache—Lacosamide—epilepsy syndrome	0.000668	0.00265	CcSEcCtD
Tafluprost—Dyspnoea—Felbamate—epilepsy syndrome	0.000662	0.00262	CcSEcCtD
Tafluprost—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000651	0.00258	CcSEcCtD
Tafluprost—Rhinitis—Pregabalin—epilepsy syndrome	0.000651	0.00258	CcSEcCtD
Tafluprost—Headache—Clobazam—epilepsy syndrome	0.000649	0.00257	CcSEcCtD
Tafluprost—Dyspnoea—Zonisamide—epilepsy syndrome	0.000648	0.00257	CcSEcCtD
Tafluprost—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000647	0.00257	CcSEcCtD
Tafluprost—Urinary tract infection—Gabapentin—epilepsy syndrome	0.000644	0.00255	CcSEcCtD
Tafluprost—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000629	0.00249	CcSEcCtD
Tafluprost—Asthma—Topiramate—epilepsy syndrome	0.000626	0.00248	CcSEcCtD
Tafluprost—Dyspnoea—Clonazepam—epilepsy syndrome	0.000624	0.00248	CcSEcCtD
Tafluprost—Dyspnoea—Phenytoin—epilepsy syndrome	0.00062	0.00246	CcSEcCtD
Tafluprost—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000617	0.00245	CcSEcCtD
Tafluprost—Pruritus—Propofol—epilepsy syndrome	0.000607	0.0024	CcSEcCtD
Tafluprost—Eye disorder—Pregabalin—epilepsy syndrome	0.000607	0.0024	CcSEcCtD
Tafluprost—Rhinitis—Gabapentin—epilepsy syndrome	0.000597	0.00236	CcSEcCtD
Tafluprost—Pruritus—Midazolam—epilepsy syndrome	0.000593	0.00235	CcSEcCtD
Tafluprost—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000592	0.00235	CcSEcCtD
Tafluprost—Vision blurred—Valproic Acid—epilepsy syndrome	0.000589	0.00233	CcSEcCtD
Tafluprost—Pruritus—Levetiracetam—epilepsy syndrome	0.000586	0.00232	CcSEcCtD
Tafluprost—Headache—Acetazolamide—epilepsy syndrome	0.000578	0.00229	CcSEcCtD
Tafluprost—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000572	0.00227	CcSEcCtD
Tafluprost—Pruritus—Fosphenytoin—epilepsy syndrome	0.000566	0.00224	CcSEcCtD
Tafluprost—Eye disorder—Gabapentin—epilepsy syndrome	0.000556	0.0022	CcSEcCtD
Tafluprost—Pruritus—Vigabatrin—epilepsy syndrome	0.000551	0.00218	CcSEcCtD
Tafluprost—Cough—Valproic Acid—epilepsy syndrome	0.000545	0.00216	CcSEcCtD
Tafluprost—Pruritus—Diazepam—epilepsy syndrome	0.000543	0.00215	CcSEcCtD
Tafluprost—Urinary tract infection—Topiramate—epilepsy syndrome	0.000542	0.00215	CcSEcCtD
Tafluprost—Headache—Propofol—epilepsy syndrome	0.000537	0.00213	CcSEcCtD
Tafluprost—Vision blurred—Pregabalin—epilepsy syndrome	0.000532	0.00211	CcSEcCtD
Tafluprost—Headache—Midazolam—epilepsy syndrome	0.000525	0.00208	CcSEcCtD
Tafluprost—Pruritus—Felbamate—epilepsy syndrome	0.000525	0.00208	CcSEcCtD
Tafluprost—Headache—Levetiracetam—epilepsy syndrome	0.000519	0.00206	CcSEcCtD
Tafluprost—Pruritus—Zonisamide—epilepsy syndrome	0.000514	0.00204	CcSEcCtD
Tafluprost—Rhinitis—Topiramate—epilepsy syndrome	0.000502	0.00199	CcSEcCtD
Tafluprost—Headache—Fosphenytoin—epilepsy syndrome	0.000501	0.00198	CcSEcCtD
Tafluprost—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.0005	0.00198	CcSEcCtD
Tafluprost—Pruritus—Clonazepam—epilepsy syndrome	0.000496	0.00196	CcSEcCtD
Tafluprost—Cough—Pregabalin—epilepsy syndrome	0.000493	0.00195	CcSEcCtD
Tafluprost—Pruritus—Phenytoin—epilepsy syndrome	0.000492	0.00195	CcSEcCtD
Tafluprost—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00049	0.00194	CcSEcCtD
Tafluprost—Vision blurred—Gabapentin—epilepsy syndrome	0.000488	0.00194	CcSEcCtD
Tafluprost—Headache—Vigabatrin—epilepsy syndrome	0.000488	0.00193	CcSEcCtD
Tafluprost—Headache—Diazepam—epilepsy syndrome	0.000481	0.0019	CcSEcCtD
Tafluprost—Pruritus—Carbamazepine—epilepsy syndrome	0.00047	0.00186	CcSEcCtD
Tafluprost—Eye disorder—Topiramate—epilepsy syndrome	0.000468	0.00185	CcSEcCtD
Tafluprost—Headache—Felbamate—epilepsy syndrome	0.000465	0.00184	CcSEcCtD
Tafluprost—Headache—Zonisamide—epilepsy syndrome	0.000455	0.0018	CcSEcCtD
Tafluprost—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000455	0.0018	CcSEcCtD
Tafluprost—Pruritus—Lamotrigine—epilepsy syndrome	0.000454	0.0018	CcSEcCtD
Tafluprost—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000452	0.00179	CcSEcCtD
Tafluprost—Cough—Gabapentin—epilepsy syndrome	0.000452	0.00179	CcSEcCtD
Tafluprost—Headache—Clonazepam—epilepsy syndrome	0.000439	0.00174	CcSEcCtD
Tafluprost—Headache—Phenytoin—epilepsy syndrome	0.000436	0.00173	CcSEcCtD
Tafluprost—Headache—Oxcarbazepine—epilepsy syndrome	0.000434	0.00172	CcSEcCtD
Tafluprost—Headache—Carbamazepine—epilepsy syndrome	0.000416	0.00165	CcSEcCtD
Tafluprost—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000415	0.00164	CcSEcCtD
Tafluprost—Dyspnoea—Pregabalin—epilepsy syndrome	0.000411	0.00163	CcSEcCtD
Tafluprost—Vision blurred—Topiramate—epilepsy syndrome	0.000411	0.00163	CcSEcCtD
Tafluprost—Headache—Lamotrigine—epilepsy syndrome	0.000402	0.00159	CcSEcCtD
Tafluprost—Cough—Topiramate—epilepsy syndrome	0.00038	0.00151	CcSEcCtD
Tafluprost—Dyspnoea—Gabapentin—epilepsy syndrome	0.000377	0.00149	CcSEcCtD
Tafluprost—Pruritus—Valproic Acid—epilepsy syndrome	0.000361	0.00143	CcSEcCtD
Tafluprost—Nervous system disorder—Topiramate—epilepsy syndrome	0.000349	0.00138	CcSEcCtD
Tafluprost—Pruritus—Pregabalin—epilepsy syndrome	0.000326	0.00129	CcSEcCtD
Tafluprost—Headache—Valproic Acid—epilepsy syndrome	0.00032	0.00127	CcSEcCtD
Tafluprost—Dyspnoea—Topiramate—epilepsy syndrome	0.000317	0.00126	CcSEcCtD
Tafluprost—Pruritus—Gabapentin—epilepsy syndrome	0.000299	0.00119	CcSEcCtD
Tafluprost—Headache—Pregabalin—epilepsy syndrome	0.000289	0.00114	CcSEcCtD
Tafluprost—Headache—Gabapentin—epilepsy syndrome	0.000265	0.00105	CcSEcCtD
Tafluprost—Pruritus—Topiramate—epilepsy syndrome	0.000252	0.000997	CcSEcCtD
Tafluprost—Headache—Topiramate—epilepsy syndrome	0.000223	0.000883	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—SST—epilepsy syndrome	0.000159	0.000965	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000159	0.000965	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000159	0.000964	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000158	0.000955	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000156	0.000945	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SSTR1—epilepsy syndrome	0.000156	0.000945	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR9—epilepsy syndrome	0.000156	0.000945	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NPY2R—epilepsy syndrome	0.000156	0.000945	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR8—epilepsy syndrome	0.000156	0.000945	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000156	0.000944	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ALB—epilepsy syndrome	0.000153	0.000927	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GRM4—epilepsy syndrome	0.000153	0.000926	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GRM3—epilepsy syndrome	0.000153	0.000926	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CA13—epilepsy syndrome	0.000153	0.000926	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	0.000152	0.00092	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—DUSP4—epilepsy syndrome	0.00015	0.000909	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SSTR2—epilepsy syndrome	0.00015	0.000909	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.00015	0.000907	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.00015	0.000907	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000147	0.00089	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000147	0.000887	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—BCL2—epilepsy syndrome	0.000146	0.000886	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GRM8—epilepsy syndrome	0.000145	0.000878	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PGF—epilepsy syndrome	0.000145	0.000878	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—SST—epilepsy syndrome	0.000145	0.000876	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR2—epilepsy syndrome	0.000145	0.000876	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—NOS2—epilepsy syndrome	0.000144	0.000872	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000144	0.000869	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—epilepsy syndrome	0.000142	0.000861	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—POMC—epilepsy syndrome	0.000142	0.00086	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000142	0.000857	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCL2—epilepsy syndrome	0.000139	0.000841	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDXK—epilepsy syndrome	0.000138	0.000838	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GNAO1—epilepsy syndrome	0.000138	0.000838	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—OPRD1—epilepsy syndrome	0.000138	0.000838	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—RELA—epilepsy syndrome	0.000138	0.000835	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000137	0.000828	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000136	0.000824	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000136	0.000824	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	0.000134	0.000811	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CNR1—epilepsy syndrome	0.000134	0.000809	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	0.000133	0.000807	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000133	0.000806	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	0.000133	0.000805	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR7—epilepsy syndrome	0.000133	0.000803	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDYN—epilepsy syndrome	0.000133	0.000803	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CHRM1—epilepsy syndrome	0.000133	0.000803	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GRM1—epilepsy syndrome	0.000133	0.000803	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.000132	0.000797	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR7—epilepsy syndrome	0.00013	0.000789	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	0.00013	0.000787	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PNPO—epilepsy syndrome	0.000127	0.000766	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EPM2A—epilepsy syndrome	0.000127	0.000766	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NHLRC1—epilepsy syndrome	0.000127	0.000766	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000127	0.000766	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000125	0.000755	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GAL—epilepsy syndrome	0.000125	0.000755	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GFAP—epilepsy syndrome	0.000125	0.000755	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	0.000125	0.000755	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT3—epilepsy syndrome	0.000124	0.000752	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CHRM3—epilepsy syndrome	0.000123	0.000747	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GRM5—epilepsy syndrome	0.000123	0.000747	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP2—epilepsy syndrome	0.000123	0.000747	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000123	0.000745	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AVP—epilepsy syndrome	0.000121	0.000731	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000118	0.000716	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SV2A—epilepsy syndrome	0.000118	0.000713	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CHRM2—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FAR1—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADK—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PDXK—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GLUD1—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CERS1—epilepsy syndrome	0.000116	0.000702	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CDC42—epilepsy syndrome	0.000113	0.000686	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GABBR1—epilepsy syndrome	0.000113	0.000683	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AVP—epilepsy syndrome	0.00011	0.000664	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HRH3—epilepsy syndrome	0.000108	0.000655	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—OPRM1—epilepsy syndrome	0.000107	0.000645	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PNPO—epilepsy syndrome	0.000106	0.000642	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GAMT—epilepsy syndrome	0.000106	0.000642	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—EPM2A—epilepsy syndrome	0.000106	0.000642	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	0.000106	0.000642	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PFKL—epilepsy syndrome	0.000105	0.000635	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000103	0.000622	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.000101	0.000613	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR3—epilepsy syndrome	0.000101	0.000609	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000101	0.000608	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	9.86e-05	0.000597	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—QDPR—epilepsy syndrome	9.86e-05	0.000597	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CA4—epilepsy syndrome	9.86e-05	0.000597	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	9.84e-05	0.000595	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NPY—epilepsy syndrome	9.8e-05	0.000593	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ATP2A2—epilepsy syndrome	9.8e-05	0.000593	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STX1B—epilepsy syndrome	9.6e-05	0.000581	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AGT—epilepsy syndrome	9.54e-05	0.000577	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HSPB1—epilepsy syndrome	9.46e-05	0.000572	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CRH—epilepsy syndrome	9.46e-05	0.000572	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—OXT—epilepsy syndrome	9.46e-05	0.000572	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL2—epilepsy syndrome	9.46e-05	0.000572	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL3—epilepsy syndrome	9.46e-05	0.000572	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR5—epilepsy syndrome	9.33e-05	0.000565	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	9.3e-05	0.000563	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—COX3—epilepsy syndrome	9.27e-05	0.000561	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR2A—epilepsy syndrome	9.13e-05	0.000553	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	9.05e-05	0.000548	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPP1R3C—epilepsy syndrome	8.92e-05	0.00054	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CPSF4—epilepsy syndrome	8.92e-05	0.00054	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GBE1—epilepsy syndrome	8.92e-05	0.00054	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	8.85e-05	0.000535	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.82e-05	0.000533	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TSC1—epilepsy syndrome	8.79e-05	0.000532	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTK2B—epilepsy syndrome	8.79e-05	0.000532	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	8.79e-05	0.000532	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	8.79e-05	0.000532	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	8.79e-05	0.000532	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PFKL—epilepsy syndrome	8.79e-05	0.000532	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—KCNB1—epilepsy syndrome	8.79e-05	0.000532	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AGT—epilepsy syndrome	8.66e-05	0.000524	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.59e-05	0.00052	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SST—epilepsy syndrome	8.55e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR2—epilepsy syndrome	8.55e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NTRK2—epilepsy syndrome	8.55e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.54e-05	0.000517	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—DUSP6—epilepsy syndrome	8.48e-05	0.000513	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADRA2A—epilepsy syndrome	8.37e-05	0.000507	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PLAT—epilepsy syndrome	8.34e-05	0.000504	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BDKRB2—epilepsy syndrome	8.04e-05	0.000487	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL12—epilepsy syndrome	8.04e-05	0.000487	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UPB1—epilepsy syndrome	8.04e-05	0.000486	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ATIC—epilepsy syndrome	8.04e-05	0.000486	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NEU1—epilepsy syndrome	8.04e-05	0.000486	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—POMC—epilepsy syndrome	8.03e-05	0.000486	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PRKCB—epilepsy syndrome	8.01e-05	0.000484	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	7.99e-05	0.000484	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6ST—epilepsy syndrome	7.97e-05	0.000482	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JUNB—epilepsy syndrome	7.89e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CNR1—epilepsy syndrome	7.89e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PLCB1—epilepsy syndrome	7.87e-05	0.000476	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	7.74e-05	0.000468	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR7—epilepsy syndrome	7.7e-05	0.000466	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	7.59e-05	0.000459	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HBEGF—epilepsy syndrome	7.48e-05	0.000452	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	7.47e-05	0.000452	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GBE1—epilepsy syndrome	7.47e-05	0.000452	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ST3GAL3—epilepsy syndrome	7.43e-05	0.000449	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT3—epilepsy syndrome	7.34e-05	0.000444	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.31e-05	0.000442	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—POMC—epilepsy syndrome	7.29e-05	0.000441	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADAM10—epilepsy syndrome	7.17e-05	0.000434	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	7.16e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL2—epilepsy syndrome	7.14e-05	0.000432	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ASAH1—epilepsy syndrome	7.03e-05	0.000425	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—STXBP1—epilepsy syndrome	6.84e-05	0.000414	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—S100B—epilepsy syndrome	6.78e-05	0.00041	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SOCS3—epilepsy syndrome	6.71e-05	0.000406	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDC42—epilepsy syndrome	6.7e-05	0.000405	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	6.69e-05	0.000405	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NT5E—epilepsy syndrome	6.66e-05	0.000403	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALAD—epilepsy syndrome	6.66e-05	0.000403	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	6.5e-05	0.000393	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AVP—epilepsy syndrome	6.48e-05	0.000392	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	6.36e-05	0.000385	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	6.36e-05	0.000385	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	6.22e-05	0.000376	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HES1—epilepsy syndrome	6.13e-05	0.000371	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADSL—epilepsy syndrome	6.09e-05	0.000369	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GLUL—epilepsy syndrome	5.98e-05	0.000362	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FYN—epilepsy syndrome	5.96e-05	0.000361	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—H2AFX—epilepsy syndrome	5.94e-05	0.000359	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MEF2C—epilepsy syndrome	5.93e-05	0.000359	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	5.86e-05	0.000355	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.83e-05	0.000353	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—YWHAZ—epilepsy syndrome	5.73e-05	0.000347	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	5.68e-05	0.000344	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NGF—epilepsy syndrome	5.67e-05	0.000343	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR5—epilepsy syndrome	5.51e-05	0.000334	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	5.49e-05	0.000332	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EIF2AK2—epilepsy syndrome	5.41e-05	0.000327	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR2A—epilepsy syndrome	5.39e-05	0.000326	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AQP1—epilepsy syndrome	5.33e-05	0.000322	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TSC2—epilepsy syndrome	5.12e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AGT—epilepsy syndrome	5.12e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.12e-05	0.000309	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOE—epilepsy syndrome	5.02e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPIA—epilepsy syndrome	5e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KDR—epilepsy syndrome	4.91e-05	0.000297	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.87e-05	0.000295	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	4.82e-05	0.000291	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CHRM3—epilepsy syndrome	4.82e-05	0.000291	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCB—epilepsy syndrome	4.73e-05	0.000286	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6ST—epilepsy syndrome	4.71e-05	0.000285	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.49e-05	0.000271	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.39e-05	0.000266	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—POMC—epilepsy syndrome	4.31e-05	0.000261	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL2—epilepsy syndrome	4.22e-05	0.000255	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCG2—epilepsy syndrome	3.93e-05	0.000238	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	3.83e-05	0.000232	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGF2—epilepsy syndrome	3.81e-05	0.000231	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	3.8e-05	0.00023	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.78e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC2A1—epilepsy syndrome	3.71e-05	0.000224	CbGpPWpGaD
Tafluprost—PTGS2—Disease—JUNB—epilepsy syndrome	3.68e-05	0.000223	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS1—epilepsy syndrome	3.65e-05	0.000221	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.62e-05	0.000219	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RELA—epilepsy syndrome	3.54e-05	0.000214	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HBEGF—epilepsy syndrome	3.48e-05	0.000211	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MTOR—epilepsy syndrome	3.47e-05	0.00021	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.44e-05	0.000208	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	3.43e-05	0.000208	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT3—epilepsy syndrome	3.42e-05	0.000207	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ADAM10—epilepsy syndrome	3.34e-05	0.000202	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	3.27e-05	0.000198	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—BCHE—epilepsy syndrome	3.25e-05	0.000197	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT1—epilepsy syndrome	3.22e-05	0.000195	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP3—epilepsy syndrome	3.19e-05	0.000193	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDC42—epilepsy syndrome	3.12e-05	0.000189	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	3.1e-05	0.000188	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JUN—epilepsy syndrome	3.1e-05	0.000187	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLCB1—epilepsy syndrome	3.07e-05	0.000186	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—TH—epilepsy syndrome	3.06e-05	0.000185	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—epilepsy syndrome	3.01e-05	0.000182	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT1—epilepsy syndrome	2.92e-05	0.000177	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HES1—epilepsy syndrome	2.86e-05	0.000173	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SRC—epilepsy syndrome	2.78e-05	0.000168	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FYN—epilepsy syndrome	2.78e-05	0.000168	CbGpPWpGaD
Tafluprost—PTGS2—Disease—H2AFX—epilepsy syndrome	2.77e-05	0.000167	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—epilepsy syndrome	2.71e-05	0.000164	CbGpPWpGaD
Tafluprost—PTGS2—Disease—YWHAZ—epilepsy syndrome	2.67e-05	0.000162	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CCR5—epilepsy syndrome	2.57e-05	0.000155	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HMOX1—epilepsy syndrome	2.55e-05	0.000154	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAT—epilepsy syndrome	2.52e-05	0.000152	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCB1—epilepsy syndrome	2.45e-05	0.000148	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TSC2—epilepsy syndrome	2.39e-05	0.000144	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOE—epilepsy syndrome	2.34e-05	0.000141	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GPX1—epilepsy syndrome	2.28e-05	0.000138	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6ST—epilepsy syndrome	2.2e-05	0.000133	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS2—epilepsy syndrome	2.18e-05	0.000132	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AGT—epilepsy syndrome	2e-05	0.000121	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOE—epilepsy syndrome	1.96e-05	0.000118	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGF2—epilepsy syndrome	1.78e-05	0.000107	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT1—epilepsy syndrome	1.73e-05	0.000104	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—POMC—epilepsy syndrome	1.68e-05	0.000102	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTOR—epilepsy syndrome	1.62e-05	9.78e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—epilepsy syndrome	1.53e-05	9.27e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SRC—epilepsy syndrome	1.3e-05	7.84e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT1—epilepsy syndrome	8.05e-06	4.87e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKT1—epilepsy syndrome	6.74e-06	4.08e-05	CbGpPWpGaD
